Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $117.26 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $100.28 | 1 | $0 (2024) |
| Novo Nordisk Inc | $16.98 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100.28 | 1 | Janssen Pharmaceuticals, Inc ($100.28) |
| 2021 | $16.98 | 1 | Novo Nordisk Inc ($16.98) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $100.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 430 | 638 | $138,695 | $21,430 |
| 2022 | 12 | 549 | 687 | $170,351 | $37,765 |
| 2021 | 11 | 461 | 505 | $191,487 | $53,918 |
| 2020 | 4 | 146 | 148 | $35,237 | $6,693 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 220 | 320 | $86,050 | $12,968 | 15.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 48 | 49 | $33,222 | $4,105 | 12.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 42 | 43 | $9,503 | $2,972 | 31.3% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 19 | 19 | $7,657 | $947.67 | 12.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 39 | $1,630 | $281.39 | 17.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 28 | $196.00 | $57.20 | 29.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 14 | $154.00 | $47.74 | 31.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 52 | $165.36 | $26.60 | 16.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 15 | 74 | $117.66 | $24.62 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 315 | $85,998 | $16,416 | 19.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 55 | 58 | $24,824 | $8,122 | 32.7% |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | Office | 2022 | 15 | 15 | $19,305 | $6,015 | 31.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 57 | 57 | $19,380 | $3,116 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 21 | $8,064 | $1,675 | 20.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 33 | 34 | $7,514 | $1,037 | 13.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 16 | 16 | $2,464 | $819.94 | 33.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 45 | 55 | $2,365 | $439.39 | 18.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 36 | 43 | $301.00 | $95.49 | 31.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 32 | 44 | $72.08 | $15.43 | 21.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 11 | 18 | $63.54 | $12.52 | 19.7% |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | Office | 2022 | 11 | 11 | $0.11 | $0.11 | 100.0% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2021 | 69 | 69 | $88,803 | $29,589 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 146 | 176 | $48,224 | $10,203 | 21.2% |
| 0241U | Nfct ds vir resp rna 4 trgt | Office | 2021 | 44 | 45 | $19,260 | $6,418 | 33.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 43 | 43 | $14,549 | $2,671 | 18.4% |
About Darian Jones, APRN
Darian Jones, APRN is a Family healthcare provider based in Wauchula, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2019. The National Provider Identifier (NPI) number assigned to this provider is 1487128393.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Darian Jones, APRN has received a total of $117.26 in payments from pharmaceutical and medical device companies, with $100.28 received in 2024. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($117.26).
As a Medicare-enrolled provider, Jones has provided services to 1,586 Medicare beneficiaries, totaling 1,978 services with total Medicare billing of $119,806. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Wauchula, FL
- Active Since 01/14/2019
- Last Updated 11/03/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1487128393
Products in Payments
- XARELTO (Drug) $100.28
- Ozempic (Drug) $16.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Wauchula
David Blalock, Arnp, ARNP
Family — Payments: $2,454
Deborah Zolkos, Aprn, APRN
Family — Payments: $1,307
Evan Mae Lachica
Family — Payments: $453.58
Alida Pena Gonzalez, Arnp, ARNP
Family — Payments: $129.90
Jennifer Warras, Aprn-Fnp-C, APRN-FNP-C
Family — Payments: $121.72
Ms. Brittany Davidson, Fnp-C, FNP-C
Family — Payments: $14.35